|
Babcock & Wilcox Technical Services Group (B&W TSG) has been awarded $9 million from the National Nuclear Security Administration for the development of reactor technology for medical isotope production using low enriched uranium.
The Nuclear Research and Consultancy Group, which operates the High Flux Reactor in Petten, Netherlands, has plans to build a new reactor to produce medical isotopes.
Reps. Edward J. Markey, D-Mass., Chairman of the House Energy and Commerce Committee Subcommittee on Energy and the Environment, and Fred Upton, R-Mich., the Ranking Member of the Subcommittee, have introduced the American Medical Isotopes Production Act, which seeks to ensure that a reliable supply of critical medical isotopes are produced in the United States.
Lantheus Medical Imaging has been granted a supplemental new drug application from the FDA and a supplemental new drug submission from Health Canada to qualify the Australian Nuclear Science and Technology Organization as a valid supplier for low-enriched uranium-derived molybdenum-99 (Mo-99) to the United States and Canada.
Lantheus Medical Imaging has finalized an arrangement with the Australian Nuclear Science and Technology Organization to receive molybdenum-99 (Mo-99) produced from low-enriched uranium targets in its new Open Pool Australian Lightwater reactor.
Rep. Edward J. Markey, D-Mass., chairman of the House Energy and Commerce Subcommittee on Energy and Environment, plans to introduce legislation that would help create a domestic market that produces medical isotopes using low enriched uranium (LEU), moving the industry away from its dependence on highly enriched uranium.
|
Advanced Medical Isotope Corporation (AMIC) has achieved "encouraging results" from initial tests of its accelerator technology for the domestic production of molybdenum-99 (Mo-99).
The American College of Radiology, SNM and a coalition of seven other organizations are urging Congress to take steps to maintain adequate supplies of molybdenum-99 (Mo-99).
The extended shutdown of the troubled nuclear reactor at Chalk River has the U.S. government poised to invest millions to get back into the business of medical isotopes--a move that could eventually push Canada out of that industry, according to a report in the Toronto Star.
In response to the recurring global medical isotope crisis, SNM has issued a call-to-action plan highlighting its commitment to finding a solution to eliminate future molybydenum-99 (Mo-99) supply disruptions.
Operators of the 250 global nuclear reactors, which are used for scientific testing and the production of medical isotopes, met this week in Vienna, Austria, to tackle isotope shortages and fuel risks at a meeting supported by the United Nations (UN), according to the International Atomic Energy Agency.
|
RSS 
The use of health IT to reduce rehospitalizations will be welcome but also disruptive, said Stephen Jencks, an independent consultant in healthcare safety during a Feb. 24 webinar on the potential use of health IT to mitigate rehospitalizations, sponsored by the Agency for Healthcare Research and Quality (AHRQ).
During the Health IT Standards Committee meeting on Feb. 24 in Washington, D.C., the Clinical Operations Workgroup sought to gather comments on proposed recommendations on implementation specifications for content exchange, vocabulary and code set standards for the Interim Final Rule of meaningful use.
In 2006, the Center for Devices and Radiological Health (CDRH), a branch of the FDA, began examining the number of medical device reports they received. Over the past two years, the number of submitted reports has increased, sparking a demand for the CDRH to make a move to electronic reporting.
A new hospital breaking ground usually isn’t breaking news. But the vision of patient care at one new facility, tentatively named Palomar Medical Center West (PMC West), is currently illegal under California state law.